Boosting hepatitis C treatment would save money, CBO says

Doubling the number of Medicaid enrollees receiving hepatitis C treatments would avoid about $7 billion in health care costs over a decade, according to a new Congressional Budget Office report on the burden the liver disease places on medical care and safety net programs.